Amyopathic necrotizing dermatomyositis secondary to an underlying malignancy: A case report and review of the literature

Cutis

Volumn 82, Issue 6, 2008, Pages 407-413

  Ritchie, Simon A ^a   Kobayashi, Todd ^b   Sperling, Leonard ^c  

^a USAF   (United States)

^b UNITED STATES AIR FORCE ACADEMY   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ARTICLE; CASE REPORT; DERMATOMYOSITIS; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; SMALL CELL CARCINOMA;

AUTOANTIBODIES; CARCINOMA, SMALL CELL; DERMATOMYOSITIS; FEMALE; HUMANS; MIDDLE AGED; NECROSIS; SKIN;

EID: 60749102634     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Costner MI, Grau RH. Update on connective tissue diseases in dermatology. Semin Cutan Med Surg. 2006;25: 207-220.
2. Nagaraju K, Rider LG, Fan C, et al. Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis. 2006;3:1-8.
3. Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol. 2006;25:234-239.
4. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357: 96-100.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-347.
6. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403-407.
7. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis siné myositis). presentation of six new cases and review of the literature. J Am Acad Dermatol. 1991;24(6, pt l):959-966.
8. el-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol. 2002;46:560-565.
9. Neves Fde S, Shinjo SK, Carvalho JF, et al. Spontaneous pneumomediastinum and dermatomyositis may be a not so rare association: report of a case and review of the literature. Clin Rheumatol. 2007;26:105-107.
10. Dourmishev LA, Wollina U. Dermatomyositis: immunopathologic study of skin lesions. Acta Dermatovenerol Alp Panonica Adriat. 2006;15:45-51.
11. Mascaró JM Jr, Hausmann G, Herrero C, et al. Membrane attack complex deposits in cutaneous lesions of dermatomyositis. Arch Dermatol. 1995;131:1386-1392.
12. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 1996;27:15-19.
13. Gerami P Schope JM, McDonald L, et al. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54:597-613.
14. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-982.
15. Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine. 2006;73:646-654.
16. Ascherman DP, Oriss TB, Oddis CV, et al. Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis. J Immunol. 2002;169:7127-7134.
17. Page G, Chevrel G, Miossec P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 2004;50:199-208.
18. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer. 2001;85:41-45.
19. Kaji K, Fujimoto M, Hasegawa M, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007;46:25-28.
20. Sato S. Autoantibodies specifically detected in patients with polymyositis/dermatomyositis [in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi. 2006;29:85-93.
21. Dalakas MC. The molecular and cellular pathology of inflammatory muscle diseases. Curr Opin Pharmacol. 2001;1:300-306.
22. Vianna MA, Borges CT, Borba EF, et al. Myositis in mixed connective tissue disease: a unique syndrome characterized by immunohistopathologic elements of both polymyositis and dermatomyositis. Arq Neuropsiquiatr. 2004;62:923-934.
23. Shimojima Y, Ishii W, Kato T, et al. Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A. Intern Med. 2003;42:1253-1258.
24. Parodi A, Caproni M, Marzano AV, et al. Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies. Acta Derm Venereol. 2002;82:48-51.
25. Antonioli CM, Airo P. Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma. Clin Rheumatol. 2004;23: 239-241.
26. Kojima M, Itoh H, Shimizu K, et al. Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases. Int J Surg Pathol. 2006;14:43-48.
27. Airio A, Pukkala E, Isomaki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol. 1995;22:1300-1303.
28. Chow WH, Gridley G, Mellemkjaer L, et al. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 1995;6:9-13.
29. Osako T, Ito Y, Morimatsu A, et al. Flare-up of dermatomyositis along with recurrence of breast cancer. Breast J. 2007;13:200-202.
30. Yasuda E, Takeshita A, Murata S, et al. Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature. Pathol Int. 2006;56:749-754.
31. Szekanecz E, Andras C, Sandor Z, et al. Malignancies and soluble tumor antigens in rheumatic diseases. Autoimmun Rev. 2006;6:42-47.
32. Lakhanpal S, Bunch TW, Ilstrup DM, et al. Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc. 1986;61:645-653.
33. Cherin P, Piette JC, Herson S, et al. Dermatomyositis and ovarian cancer: a report of 7 cases and literature review. J Rheumatol. 1993;20:1897-1899.
34. Ben-Zvi N, Shani A, Ben-Baruch G, et al. Dermatomyositis following the diagnosis of ovarian cancer. Int J Gynecol Cancer. 2005;15:1124-1126.
35. Fung WK, Chan HL, Lam WM. Amyopathic dermatomyositis in Hong Kong - association with nasopharyngeal carcinoma. Int J Dermatol. 1998;37:659-663.
36. Osman Y, Narita M, Kishi K, et al. Case report: amyopathic dermatomyositis associated with transformed malignant lymphoma. Am J Med Sci. 1996;311: 240-242.
37. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol. 1993;100:124S-127S.
38. Caproni M, Cardinali C, Parodi A, et al. Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology. Arch Dermatol. 2002;138:23-27.
39. Scheinfeld NS. Ulcerative paraneoplastic dermatomyositis secondary to metastatic breast cancer. Skinmed. 2006;5:94-96.